These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9437905)

  • 1. [Measurement of fecal lactoferrin for diagnosis on pediatric gastrointestinal disease].
    Tabata K; Matsuse R; Uchida K; Amemoto K
    Rinsho Byori; 1997 Dec; 45(12):1201-3. PubMed ID: 9437905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fecal lactoferrin as a marker for disease activity in inflammatory bowel disease: comparison with other neutrophil-derived proteins.
    Sugi K; Saitoh O; Hirata I; Katsu K
    Am J Gastroenterol; 1996 May; 91(5):927-34. PubMed ID: 8633583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal eosinophil granule-derived proteins reflect disease activity in inflammatory bowel disease.
    Saitoh O; Kojima K; Sugi K; Matsuse R; Uchida K; Tabata K; Nakagawa K; Kayazawa M; Hirata I; Katsu K
    Am J Gastroenterol; 1999 Dec; 94(12):3513-20. PubMed ID: 10606313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
    Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
    Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal lactoferrin is a sensitive and specific marker of disease activity in children and young adults with inflammatory bowel disease.
    Walker TR; Land ML; Kartashov A; Saslowsky TM; Lyerly DM; Boone JH; Rufo PA
    J Pediatr Gastroenterol Nutr; 2007 Apr; 44(4):414-22. PubMed ID: 17414136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation.
    Kane SV; Sandborn WJ; Rufo PA; Zholudev A; Boone J; Lyerly D; Camilleri M; Hanauer SB
    Am J Gastroenterol; 2003 Jun; 98(6):1309-14. PubMed ID: 12818275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Significance of fecal lactoferrin in evaluation of disease activity in ulcerative colitis].
    Xiang JY; Ouyang Q; Li GD
    Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(32):2262-4. PubMed ID: 18001547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of a rapid fecal latex agglutination test detecting the neutrophil protein, lactoferrin, for diagnosing inflammatory causes of chronic diarrhea.
    Fine KD; Ogunji F; George J; Niehaus MD; Guerrant RL
    Am J Gastroenterol; 1998 Aug; 93(8):1300-5. PubMed ID: 9707055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between fecal lactoferrin and inflammatory bowel disease.
    Dai J; Liu WZ; Zhao YP; Hu YB; Ge ZZ
    Scand J Gastroenterol; 2007 Dec; 42(12):1440-4. PubMed ID: 17852860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of four fecal assays in the diagnosis of colitis.
    Schoepfer AM; Trummler M; Seeholzer P; Criblez DH; Seibold F
    Dis Colon Rectum; 2007 Oct; 50(10):1697-706. PubMed ID: 17762964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal calprotectin and lactoferrin as noninvasive markers of pediatric inflammatory bowel disease.
    Joishy M; Davies I; Ahmed M; Wassel J; Davies K; Sayers A; Jenkins H
    J Pediatr Gastroenterol Nutr; 2009 Jan; 48(1):48-54. PubMed ID: 19172123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fecal excretion of alpha 2-macroglobulin: a novel marker for disease activity in patients with inflammatory bowel disease.
    Becker K; Niederau C; Frieling T
    Z Gastroenterol; 1999 Jul; 37(7):597-605. PubMed ID: 10458008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lactoferrin in whole gut lavage fluid as a marker for disease activity in inflammatory bowel disease: comparison with other neutrophil-derived proteins.
    Kayazawa M; Saitoh O; Kojima K; Nakagawa K; Tanaka S; Tabata K; Matsuse R; Uchida K; Hoshimoto M; Hirata I; Katsu K
    Am J Gastroenterol; 2002 Feb; 97(2):360-9. PubMed ID: 11866274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phagocytosis, killing, lymphocyte-mediated antibacterial activity, serum autoantibodies, and plasma endotoxins in inflammatory bowel disease.
    Caradonna L; Amati L; Lella P; Jirillo E; Caccavo D
    Am J Gastroenterol; 2000 Jun; 95(6):1495-502. PubMed ID: 10894586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection of lactoferrin in feces for differential diagnosis in diarrhea].
    Fried K; Tárkányi K; Prinz G; Bán E
    Orv Hetil; 2002 Sep; 143(37):2141-4. PubMed ID: 12434630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The forms and the levels of fecal PMN-elastase in patients with colorectal diseases.
    Saitoh O; Sugi K; Matsuse R; Uchida K; Matsumoto H; Nakagawa K; Takada K; Yoshizumi M; Hirata I; Katsu K
    Am J Gastroenterol; 1995 Mar; 90(3):388-93. PubMed ID: 7872275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
    ; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
    J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal pyruvate kinase: a potential new marker for intestinal inflammation in children with inflammatory bowel disease.
    Czub E; Herzig KH; Szaflarska-Popawska A; Kiehne K; Socha P; Woś H; Kamińska B; Błaszczyński M; Cichy W; Bała G; Brodzicki J; Grzybowska-Chlebowczyk U; Walkowiak J
    Scand J Gastroenterol; 2007 Oct; 42(10):1147-50. PubMed ID: 17852864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal lactoferrin as a noninvasive biomarker in inflammatory bowel diseases.
    Langhorst J; Boone J
    Drugs Today (Barc); 2012 Feb; 48(2):149-61. PubMed ID: 22384454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advantages of fecal lactoferrin measurement during granulocyte and monocyte adsorptive apheresis therapy in ulcerative colitis.
    Hashiguchi K; Takeshima F; Akazawa Y; Matsushima K; Minami H; Machida H; Yamaguchi N; Shiozawa K; Ohba K; Ohnita K; Ichikawa T; Isomoto H; Nakao K
    Digestion; 2015; 91(3):208-17. PubMed ID: 25823500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.